Thai GACP Medical Flower on the EU-GACP Pathway
TM BioMed is a Thailand-based B2B cultivation partner focused on medical cannabis dried flower. We are advancing our operations toward EU-GACP requirements to support future collaboration with qualified companies operating in EU-GMP and regulated international medical supply chains.
EU-GACP certification is currently in progress. Any potential partnership remains subject to applicable laws, licences, documentation review, regulatory assessment, availability, and mutual agreement.
Strategic Quality Direction
Progressing Toward EU-GACP
TM BioMed is advancing its cultivation and quality-management approach toward EU-GACP requirements. This direction reflects our long-term commitment to structured documentation, responsible cultivation practices, quality consistency, and international partnership readiness.
Thai GACP Foundation
TM BioMed’s cultivation approach is built on Thai GACP principles and controlled agricultural practices.
EU-GACP Progression
We are developing operational readiness, documentation practices, and quality-management processes to support our EU-GACP pathway.
Qualified Partner Dialogue
We welcome early discussions with qualified EU-GMP and regulated-market partners to understand future supply-chain and documentation requirements.
Controlled Information Sharing
Detailed operational, technical, and commercial information is shared only with qualified counterparties through appropriate due-diligence and confidentiality processes.
EU-GACP certification is in progress and has not yet been granted. TM BioMed does not represent itself as EU-GACP or EU-GMP certified.
Primary Supply Focus
Thai GACP Medical Flower
TM BioMed focuses on medical cannabis dried flower discussions with qualified B2B partners seeking a Thailand-based cultivation partner for regulated medical-market opportunities. Product, documentation, and commercial discussions are structured around the applicable requirements of each potential destination market.
Medical Flower — Dried Cannabis
- EU-GMP-certified manufacturers and processors
- Licensed medical-cannabis importers
- Regulated distributors
- Pharmaceutical and medical-market supply-chain partners
- Qualified procurement and business-development teams
Discussion may include:
- Partner quality requirements
- Destination-market expectations
- Documentation requirements
- Product format and packaging discussion
- Availability planning
- Commercial framework
- Confidentiality and due-diligence process
Additional Biomass Discussions
Where appropriate, TM BioMed may also discuss biomass supply options with qualified extraction, processing, and manufacturing partners. Such discussions are secondary to our medical flower focus and remain subject to commercial scope, documentation requirements, regulatory considerations, and availability.
Product specifications, batch information, documentation, and commercial terms are reviewed case by case with qualified partners and remain subject to applicable requirements and availability.
Standards & Compliance
Thai GACP Foundation & EU-GACP Progression
TM BioMed’s long-term quality direction is centred on progressing from a Thai GACP cultivation foundation toward EU-GACP requirements. We recognise that international medical markets require disciplined documentation, controlled operational processes, and clear alignment with the expectations of qualified downstream partners.
Thai GACP Cultivation Foundation
Establishing the baseline operational practices, consistency, and internal review processes required for professional agricultural controls.
EU-GACP Readiness Development
Actively advancing standard operating procedures and documentation systems to bridge the gap toward European regulatory expectations.
Partner-Specific Documentation Review
Tailoring documentation and compliance information exchanges to match specific jurisdictional requirements during B2B assessments.
EU-GMP Partnership Alignment
TM BioMed seeks dialogue with qualified companies operating under EU-GMP or comparable regulated quality systems. Partner requirements are reviewed case by case.
EU-GACP certification remains in progress. No certification, export approval, product availability, or regulatory suitability is represented through this website.
Global Trade
Future EU-GMP Supply-Chain Partnerships
TM BioMed welcomes discussion with qualified companies operating within EU-GMP or other regulated medical-market supply chains. We are particularly interested in understanding the quality, documentation, and commercial requirements of partners seeking future cooperation with a Thailand-based medical flower cultivation partner.
Early engagement helps both parties assess potential alignment before moving into detailed documentation, technical review, or commercial negotiation.
Any potential cooperation is subject to applicable laws, licences, partner qualification, due diligence, documentation review, regulatory assessment, availability, and mutual written agreement.
Get In Touch
Looking for a Reliable Cannabis Supply Partner from Thailand?
Submit a qualified business enquiry and our team will review your requirements, documentation needs, and destination-market context before responding.
All enquiries are reviewed case by case. Any potential cooperation is subject to applicable laws, licences, partner qualification, due diligence, and mutual written agreement.